Episode 1- Mechanism and Interactions in Leukemia

Therapeutic resistance and the risks of progression remain an ongoing challenge for various hematological malignancies, including acute promyelocytic leukemia, chronic myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.  

Therapeutic resistance and the risks of progression remain an ongoing challenge for various hematological malignancies, including acute promyelocytic leukemia, chronic myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.  

Download it: MP3
Therapeutic resistance and the risks of progression remain an ongoing challenge for various hematological malignancies, including acute promyelocytic leukemia, chronic myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.  

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.